Description
Aripiprazole is an atypical antipsychotic widely recognized for its novel mechanism of action as a dopamine D2 receptor partial agonist and serotonin 5-HT1A/5-HT2A modulator. The injectable form offers targeted delivery for research involving rapid-onset pharmacokinetics and neurobehavioral models.
This lab-grade injectable is supplied as a 0.3g lyophilized powder, ideal for applications in neuroscience, CNS studies, and antipsychotic drug screening.
Aripiprazole for Injection Product Specifications
| Parameter | Details |
|---|---|
| Product Name | Aripiprazole for Injection |
| Generic Name | Aripiprazole |
| CAS Number | 129722-12-9 |
| Molecular Formula | C??H??Cl?N?O? |
| Molecular Weight | 448.38 g/mol |
| Formulation | Lyophilized powder for injection |
| Strength | 0.3g per vial |
| Packaging | 1 vial per box |
| Dosage Form | Injection (Freeze-dried powder) |
| Approval Number | HJ20230054 (NMPA, China) |
| Manufacturer | Otsuka Pharmaceutical Co., Ltd. (Tokushima Wajiki Factory) |
| Storage | Store at 2–8°C; protect from light and moisture |
| Intended Use | Laboratory research only |
Aripiprazole for Injection Mechanism of Action
Aripiprazole acts as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors and an antagonist at 5-HT2A receptors. This unique mechanism helps regulate dopaminergic and serotonergic activity in the brain—making it ideal for investigating schizophrenia, bipolar disorder, and neuropsychiatric modeling in lab settings.
Research Applications
Psychopharmacology: Commonly used in behavioral assays and animal models of psychosis and schizophrenia.
CNS Receptor Binding Studies: Useful for analyzing D2, D3, and 5-HT receptor profiles.
Drug Metabolism: Supports in vitro and in vivo PK/PD research on metabolic pathways.
Combination Therapy Research: Can be evaluated alongside mood stabilizers or antidepressants in lab settings.
Safety Profile & Handling
Common Lab Observations: Sedation, behavioral changes in animal models, injection site irritation.
Handling: Use gloves, mask, and aseptic technique. Reconstitute with sterile water as per instructions.
Stability: Lyophilized powder stable for 24 months when stored at 2–8°C. Use reconstituted solution promptly.
Core Keywords
Aripiprazole, Aripiprazole for Injection, CAS 129722-12-9, dopamine D2 partial agonist, atypical antipsychotic research, CNS pharmacology, lyophilized injection, lab-grade Aripiprazole, neuropsychiatric research, schizophrenia drug model, Otsuka Pharmaceutical
Research Use Only Disclaimer
This product is strictly for laboratory research use. It is not intended for human, veterinary, therapeutic, or diagnostic applications. Use only in accordance with institutional safety guidelines.


ggzyity –
You are so kind, I have received the package